This study is being done to find out if tucatinib plus T-DM1 works better to treat breast cancer than T-DM1 alone.
Tucatinib is a type of drug…
M16-067: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Subjects…
RPC-3201: Induction Study #1 - A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Induction Therapy for…
The goal of this study is to examine the effects of an acute bout of sedentary behaviors on cardiometabolic outcomes and energy metabolism in Latino…
This study will assess the effect of a 7-day course of oral cyclosporine (Neoral) on clinical outcome using the World Health Organization (WHO) COVID…
Baylor College of Medicine is recruiting 14-17 year olds living in rural communities and their parents to help us understand what affects their food…
The purpose of RADIANT study is to discovery and classify new and unusual forms of diabetes.
The purpose of this study is to gain a deeper understanding of the neurobiological underpinnings of mood disorders, focusing specifically on…
The primary objective of this phase 1, first in man trial is to determine the safety, toxicity, and feasibility of delivering autologous dendritic…
This is a Phase III, multicenter, randomized study with two arms (1:1 ratio) enrolling patients with AML relapsed/refractory after 2 or 3 prior…